Christopher Morton
Overview
Explore the profile of Christopher Morton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rokita J, Rathi K, Cardenas M, Upton K, Jayaseelan J, Cross K, et al.
Cell Rep
. 2019 Nov;
29(6):1675-1689.e9.
PMID: 31693904
Accelerating cures for children with cancer remains an immediate challenge as a result of extensive oncogenic heterogeneity between and within histologies, distinct molecular mechanisms evolving between diagnosis and relapsed disease,...
12.
Pinto E, Morton C, Rodriguez-Galindo C, McGregor L, Davidoff A, Mercer K, et al.
Clin Cancer Res
. 2013 Feb;
19(7):1740-7.
PMID: 23406775
Purpose: Pediatric adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. Conventional chemotherapeutic agents have shown limited utility and are largely ineffective in treating children with advanced ACC. The...
13.
Hartwich J, Orr W, Ng C, Spence Y, Morton C, Davidoff A
J Pediatr Surg
. 2013 Jan;
48(1):39-46.
PMID: 23331791
Introduction: The anti-tumor activity of angiogenesis inhibitors is often limited by the development of resistance to these drugs. Here we establish HIF-1α as a major factor in the development of...
14.
Wei J, Johansson P, Chen Q, Song Y, Durinck S, Wen X, et al.
Clin Cancer Res
. 2009 Aug;
15(17):5560-8.
PMID: 19706822
Purpose: microRNAs have been shown to be involved in different human cancers. We therefore have performed expression profiles on a panel of pediatric tumors to identify cancer-specific microRNAs. We also...
15.
Whiteford C, Bilke S, Greer B, Chen Q, Braunschweig T, Cenacchi N, et al.
Cancer Res
. 2007 Jan;
67(1):32-40.
PMID: 17210681
Human tumor xenografts have been used extensively for rapid screening of the efficacy of anticancer drugs for the past 35 years. The selection of appropriate xenograft models for drug testing...
16.
Kurmasheva R, Morton C, Houghton P
Curr Opin Investig Drugs
. 2005 Dec;
6(12):1215-27.
PMID: 16372407
The development of new drugs for the treatment of childhood cancer presents novel challenges, and pediatric clinical trials of a new agent are often initiated many years after testing in...
17.
Price C, Devlin J, Moore C, Morton C, Laird A
Hum Brain Mapp
. 2005 Apr;
25(1):70-82.
PMID: 15846820
The neural systems sustaining object naming were examined using the activation likelihood estimation (ALE) meta-analysis approach on the results of 16 previously published studies. The activation task in each study...